Coordinate expression of anticoagulant heparan sulfate proteoglycans and serine protease inhibitors in the rat ovary: A potent system of proteolysis control

Biology of Reproduction

Volumn 66, Issue 1, 2002, Pages 144-158

  Hasan, S ^a   Hosseini, G ^a   Princivalle, M ^a   Dong, J C ^a   Birsan, D ^a   Cagide, C ^a   De Agostini, A I ^a  

^a Fondation pour Recherches Medicales   (Switzerland)

Author keywords

Corpus luteum; Follicular development; Granulosa cells; Ovulation

Indexed keywords

ANTITHROMBIN III; IODINE 125; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEASE NEXIN I; PROTEOHEPARAN SULFATE; SERINE PROTEINASE INHIBITOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING KINETICS; BINDING SITE; CONTROLLED STUDY; CORPUS LUTEUM; FEMALE; GRANULOSA CELL; IMMUNOHISTOCHEMISTRY; MOLECULAR DYNAMICS; NONHUMAN; NORTHERN BLOTTING; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; OVULATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALIA;

EID: 0036135037     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod66.1.144     Document Type: Article

References (64)

1. Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan
2. Structure and affinity for antithrombin of heparan sulfate chains derived from basement membrane proteoglycans
3. Vascular-bed-specific hemostasis and hypercoagulable states
4. Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: Antithrombin binding on cultured endothelial cells and perfused rat aorta
5. Characterization and hormonal modulation of anticoagulant heparan sulfate proteoglycans synthesized by rat ovarian granulosa cells
6. Anticoagulant heparan sulfate proteoglycans expression in the rat ovary peaks in preovulatory granulosa cells
7. Molecular aspects of mammalian ovulation
8. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development
9. Ovarian follicular growth and development in mammals
10. Human ovarian follicular fluid has functional systems for the generation and modulation of thrombin
11. Development and disease in proteinase-deficient mice: Role of the plasminogen, matrix metalloproteinase and coagulation system
12. Studies of mice lacking plasminogen activator gene function suggest that plasmin production prior to ovulation exceeds the amount needed for optimal ovulation efficiency
13. Ovulation efficiency is reduced in mice that lack plasminogen activator gene function: Functional redundancy among physiological plasminogen activators
14. Structure of a serpin-protease complex shows inhibition by deformation
15. Coordinated expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 during corpus luteum formation and luteolysis in the adult pseudopregnant rat
16. Transient and cell-specific expression of tissue-type plasminogen activator and plasminogen-activator-inhibitor type 1 results in controlled and directed proteolysis during gonadotropin-induced ovulation
17. Coordinated and cell-specific induction of both physiological plasminogen activators creates functionally redundant mechanisms for plasmin formation during ovulation
18. Protease-nexin I as an androgen-dependent secretory product of the murine seminal vesicle
19. Kinetic immunonephelometric determination of protein concentrations in follicular fluid
20. Protein concentration in pre-ovulatory follicular fluid related to ovarian stimulation
21. Immunocytochemical localization of endogenous antithrombin III in the vasculature of rat tissues reveals locations of anticoagulantly active heparan sulfate proteoglycans
22. Transmission of conformational change from the heparin binding site to the reactive center of antithrombin
23. Ovarian intrabursal administration of insulin-like growth factor-binding protein inhibits follicle rupture in gonadotropin-treated immature female rats
24. Regulation of rat granulosa cell plasminogen activator system: Influence of interleukin-1 beta and ovarian follicular development
25. The effects of growth hormone on corpus luteum of superovulated rats
26. Simple or repeated induction of super-ovulation: A study on ovulation rates and microvessel corrosion casts in ovaries of golden hamsters
27. Gonadotropins regulate inducible cyclic adenosine 3′,5′-monophosphate early repressor in the rat ovary: Implications for inhibin alpha subunit gene expression
28. Differential partition of anticoagulant heparan sulfate proteoglycans synthesized by endothelial and fibroblastic cell lines
29. Variable and multiple expression of protease nexin-1 during mouse organogenesis and nervous system development
30. The effect of sex and age on antithrombin biosynthesis in the rat
31. Antibodies defining rat endothelial cells: Reca-1, a pan-endothelial cell-specific monoclonal antibody
32. Development of the ovarian follicular epithelium
33. Suppression of ovulation rate by antibodies to tissue-type plasminogen activator and alpha 2-antiplasmin
34. Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaties and implanting embryos
35. Plasminogen activator inhibitor-1 is an immediate early response gene in regenerating rat liver
36. A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state
37. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
38. The use of RNA probes for the analysis of gene expression
39. Abnormal expression of perlecan proteoglycan in metastatic melanomas
40. Involvement of the Fas/Fas ligand system in p53-mediated granulosa cell apoptosis during follicular development and atresia
41. Hormonal regulation of apoptosis in early antral follicles: Follicle-stimulating hormone as a major survival factor
42. Reproduction
43. Independent and synergistic actions of somatomedin-C in the stimulation of proteoglycan biosynthesis by cultured rat granulosa cells
44. Immunohistochemical detection of plasminogen activator inhibitor-1 in polycystic ovaries
45. Regulation of the plasminogen activator system in the ovary
46. Vitronectin governs the interaction between plasminogen activator inhibitor 1 and tissue-type plasminogen activator
47. Vitronectin
48. Anticoagulant properties of the vascular endothelium
49. Localized increases in ovarian vascular permeability and leucocyte accumulation after induced ovulation in rabbits
50. Structural mobility of antithrombin and its modulation by heparin
51. The anticoagulant activation of antithrombin by heparin
52. Serpins: Mobile conformations in a family of proteinase inhibitors
53. Protease specificity and heparin binding and activation of recombinant protease nexin 1
54. Functional interaction of plasminogen activator inhibitor type 1 (PAI-1) and heparin
55. Characterization of the heparin-binding site of glia-derived nexin/protease nexin-1
56. Structure-activity relationship of heparan sulphate
57. Anticoagulant heparan sulfate precursor structures in F9 embryonal carcinoma cells
58. Effect of heparin on the glia-derived-nexin-thrombin interaction
59. Regulation of protease nexin-I target protease specificity by collagen type IV
60. Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor
61. Specific glycosaminoglycans support the inhibition of thrombin by plasminogen activator inhibitor 1
62. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin
63. Regulation of extravascular coagulation by microvascular permeability
64. Oocyte retention after follicle luteinization